Trademark: 97382240
Status Date
Wednesday, January 17, 2024
Filing Date
Tuesday, April 26, 2022
Published for Opposition
Tuesday, March 28, 2023
5 Pharmaceuticals for the treatment of cytokine and growth factor related disorders
1 Biomedical compounds, namely, peptide-based cytokines used in the manufacture of pharmaceuticals
Jan 19, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2024
Sou Extension 2 Granted
Jan 17, 2024
Sou Extension 2 Filed
Jan 17, 2024
Sou Teas Extension Received
Jan 12, 2024
Teas Change Of Correspondence Received
Jan 12, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 12, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 31, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 30, 2023
Sou Extension 1 Granted
Oct 20, 2023
Sou Extension 1 Filed
Oct 30, 2023
Case Assigned To Intent To Use Paralegal
Oct 20, 2023
Sou Teas Extension Received
May 23, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 28, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2023
Published For Opposition
Mar 8, 2023
Notification Of Notice Of Publication E-Mailed
Feb 21, 2023
Approved For Pub - Principal Register
Feb 21, 2023
Examiner's Amendment Entered
Feb 21, 2023
Notification Of Examiners Amendment E-Mailed
Feb 21, 2023
Examiners Amendment E-Mailed
Feb 21, 2023
Examiners Amendment -Written
Feb 13, 2023
Assigned To Examiner
Aug 22, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 22, 2022
Teas Change Of Correspondence Received
Aug 22, 2022
Teas Change Of Owner Address Received
May 2, 2022
New Application Office Supplied Data Entered
Apr 29, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
